User profiles for TSO-FU WANG
Tso-Fu Wang花蓮慈濟醫院血液腫瘤科/慈濟大學副教授 Verified email at tzuchi.com.tw Cited by 733 |
Hematopoietic stem cell donation
SH Chen, TF Wang, KL Yang - International journal of hematology, 2013 - Springer
Allogeneic hematopoietic stem cell transplantation is now an important treatment for
numerous diseases. Donation of hematopoietic stem cells, either through bone marrow (BM) …
numerous diseases. Donation of hematopoietic stem cells, either through bone marrow (BM) …
The effect of combination therapy with propylthiouracil and cholestyramine in the treatment of Graves' hyperthyroidism
WC Tsai, D Pei, TF Wang, DA Wu, JC Li… - Clinical …, 2005 - Wiley Online Library
Objective The study aims to evaluate the efficacy of combination therapy with propylthiouracil
(PTU) and cholestyramine in the treatment of Graves’ hyperthyroidism. Background …
(PTU) and cholestyramine in the treatment of Graves’ hyperthyroidism. Background …
Flow cytometric scoring system as a diagnostic and prognostic tool in myelodysplastic syndromes
The aim of this study is to validate the clinical utility of the flow cytometric scoring system (FCSS),
quantifying phenotypic aberrancies in the myelomonocytic lineages, in the diagnosis …
quantifying phenotypic aberrancies in the myelomonocytic lineages, in the diagnosis …
[HTML][HTML] Daidzein synergizes with gefitinib to induce ROS/JNK/c-Jun activation and inhibit EGFR-STAT/AKT/ERK pathways to enhance lung adenocarcinoma cells …
…, CH Kuo, TC Shih, CM Yeh, TF Wang… - … Journal of Biological …, 2022 - ncbi.nlm.nih.gov
Lung cancer is the major cause of cancer associated mortality. Mutations in EGFR have been
implicated in lung cancer pathogenesis. Gefitinib (GF) is a RTKI (receptor tyrosine kinase …
implicated in lung cancer pathogenesis. Gefitinib (GF) is a RTKI (receptor tyrosine kinase …
[HTML][HTML] Factors associated with peripheral blood stem cell yield in volunteer donors mobilized with granulocyte colony-stimulating factors: the impact of donor …
Peripheral blood stem cells (PBSCs) are increasingly used as the source of hematopoietic
stem cells, but there are large variations in harvest outcome between individuals mobilized by …
stem cells, but there are large variations in harvest outcome between individuals mobilized by …
Calycosin alleviates H2O2‐induced astrocyte injury by restricting oxidative stress through the Akt/Nrf2/HO‐1 signaling pathway
CY Lu, CH Day, CH Kuo, TF Wang, TJ Ho… - Environmental …, 2022 - Wiley Online Library
Oxidative stress‐induced brain cell damage is a crucial factor in the pathogenesis of reactive
oxygen species (ROS)‐associated neurological diseases. Further, studies show that …
oxygen species (ROS)‐associated neurological diseases. Further, studies show that …
[HTML][HTML] Aloin and CPT-11 combination activates miRNA-133b and downregulates IGF1R-PI3K/AKT/mTOR and MEK/ERK pathways to inhibit colorectal cancer …
CPT-11 is one of the drugs employed in colorectal cancer treatment and has faced challenges
in the form of resistance. The insulin-like growth factor 1 receptor is a tyrosine kinase …
in the form of resistance. The insulin-like growth factor 1 receptor is a tyrosine kinase …
[HTML][HTML] Complete blood count reference values of cord blood in Taiwan and the influence of gender and delivery route on them
YH Chang, SH Yang, TF Wang, TY Lin, KL Yang… - Pediatrics & …, 2011 - Elsevier
Background Cord blood banking has become more popular in recent years. Checking cord
blood complete blood count (CBC) and white blood cell (WBC) differential counts (DCs) is …
blood complete blood count (CBC) and white blood cell (WBC) differential counts (DCs) is …
Association between sarcopenia and clinical outcomes in patients with esophageal cancer under neoadjuvant therapy
…, KH Lue, TC Hsieh, SH Liu, TF Wang… - Anticancer …, 2020 - ar.iiarjournals.org
Background/Aim: This study aimed to evaluate the association of sarcopenia and Clinical
Outcomes with esophageal cancer under neoadjuvant chemoradiotherapy (CRT). Patients and …
Outcomes with esophageal cancer under neoadjuvant chemoradiotherapy (CRT). Patients and …
Platycodin D reverses histone deacetylase inhibitor resistance in hepatocellular carcinoma cells by repressing ERK1/2-mediated cofilin-1 phosphorylation
WC Hsu, S Ramesh, MA Shibu, MC Chen, TF Wang… - Phytomedicine, 2021 - Elsevier
Background Chemoresistance remains the main obstacle in hepatocellular carcinoma (HCC)
therapy. Despite significant advances in HCC therapy, HCC still has a poor prognosis. …
therapy. Despite significant advances in HCC therapy, HCC still has a poor prognosis. …